Literature DB >> 23933777

How IRBs view and make decisions about social risks.

Robert L Klitzman1.   

Abstract

Whether and how IRBs assess social risks remains unclear, with little empirical investigation. I contacted leaders of 60 IRBs, and interviewed IRB leaders from 34 (response rate = 55%) and additionally, 12 members and administrators. IRBs struggle to assess and balance social risks and benefits, and vary in whether, how, and how much to do so, and how to balance these against individual risks/benefits. Risks to a group affect individuals within it. Hence, social risks can include indirect individual risks, raising ambiguities. Dilemmas emerge: e.g., how much responsibility researchers and IRBs have for addressing broader health inequities. These data, the first to examine how IRBs make decisions about social risks, reveal how IRBs face critical challenges, dilemmas, and ambiguities.

Entities:  

Mesh:

Year:  2013        PMID: 23933777      PMCID: PMC3792497          DOI: 10.1525/jer.2013.8.3.58

Source DB:  PubMed          Journal:  J Empir Res Hum Res Ethics        ISSN: 1556-2646            Impact factor:   1.742


  23 in total

1.  Characteristics of medical school faculty members serving on institutional review boards: results of a national survey.

Authors:  Eric G Campbell; Joel S Weissman; Brian Clarridge; Recai Yucel; Nancyanne Causino; David Blumenthal
Journal:  Acad Med       Date:  2003-08       Impact factor: 6.893

2.  IRBs and the long-term social implications of research.

Authors:  Inmaculada de Melo-Martin
Journal:  Am J Bioeth       Date:  2011-05       Impact factor: 11.229

3.  Institutional review board community members: who are they, what do they do, and whom do they represent?

Authors:  Robert Klitzman
Journal:  Acad Med       Date:  2012-07       Impact factor: 6.893

4.  Views and experiences of IRBs concerning research integrity.

Authors:  Robert Klitzman
Journal:  J Law Med Ethics       Date:  2011       Impact factor: 1.718

5.  How IRB leaders view and approach challenges raised by industry-funded research.

Authors:  Robert Klitzman
Journal:  IRB       Date:  2013 May-Jun

6.  Dealing with the long-term social implications of research.

Authors:  Alan Fleischman; Carol Levine; Lisa Eckenwiler; Christine Grady; Dale E Hammerschmidt; Jeremy Sugarman
Journal:  Am J Bioeth       Date:  2011-05       Impact factor: 11.229

7.  How do institutional review boards apply the federal risk and benefit standards for pediatric research?

Authors:  Seema Shah; Amy Whittle; Benjamin Wilfond; Gary Gensler; David Wendler
Journal:  JAMA       Date:  2004-01-28       Impact factor: 56.272

8.  How local IRBs view central IRBs in the US.

Authors:  Robert Klitzman
Journal:  BMC Med Ethics       Date:  2011-06-23       Impact factor: 2.652

9.  What shapes research impact on policy? Understanding research uptake in sexual and reproductive health policy processes in resource poor contexts.

Authors:  Andy Sumner; Jo Crichton; Sally Theobald; Eliya Zulu; Justin Parkhurst
Journal:  Health Res Policy Syst       Date:  2011-06-16

10.  The ethics police?: IRBs' views concerning their power.

Authors:  Robert Klitzman
Journal:  PLoS One       Date:  2011-12-13       Impact factor: 3.240

View more
  3 in total

1.  From paper to screen: regulatory and operational considerations for modernizing the informed consent process.

Authors:  Nichelle L Cobb; Dorothy F Edwards; Erin M Chin; James J Lah; Felicia C Goldstein; Cecilia M Manzanares; Christine M Suver
Journal:  J Clin Transl Sci       Date:  2022-03-28

2.  Standards of evidence for institutional review board decision-making.

Authors:  David B Resnik
Journal:  Account Res       Date:  2020-12-08       Impact factor: 3.057

3.  Consent requirements for research with human tissue: Swiss ethics committee members disagree.

Authors:  Flora Colledge; Sophie De Massougnes; Bernice Elger
Journal:  BMC Med Ethics       Date:  2018-11-26       Impact factor: 2.652

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.